STRATA Skin Sciences, Inc.
SSKNDelisted Feb 19, 2026- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001051514
STRATA Skin Sciences, Inc. was delisted on Feb 19, 2026; its insiders filed their last Form 4 on Nov 18, 2025; 14 institutions reported holding it in 13F filings for Q4 2025, worth $1.37M in total; no superinvestor held it.
13F holders, Q1 2026
Institutional positions in STRATA Skin Sciences, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
SSKN is no longer listed, and 13F filings after Q4 2025 list far fewer holders. See Q4 2025
- Institutional holders
- 0
- −13 vs. Q4 2025
- Shares held
- 0
- −1.07M (−100.0%) vs. Q4 2025
- Total value
- $0
- −$1.35M (−100.0%) vs. Q4 2025
- New holders
- 0
- 0 more added
- Sold out
- 13
- 0 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SSKN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 14 | $1.37M |
| Q3 2025 | 17 | $2.37M |
| Q2 2025 | 16 | $2.77M |
| Q1 2025 | 18 | $3.25M |
| Q4 2024 | 16 | $3.51M |
| Q3 2024 | 19 | $3.32M |
| Q2 2024 | 17 | $3.31M |
| Q1 2024 | 24 | $4.21M |
| Q4 2023 | 26 | $6.26M |
| Q3 2023 | 28 | $7.19M |
| Q2 2023 | 29 | $10.7M |
| Q1 2023 | 29 | $11.9M |
| Q4 2022 | 30 | $8.90M |
| Q3 2022 | 27 | $9.79M |
| Q2 2022 | 30 | $10.9M |
| Q1 2022 | 26 | $16.4M |
| Q4 2021 | 23 | $16.2M |
| Q3 2021 | 22 | $18.5M |
| Q2 2021 | 20 | $14.9M |
| Q1 2021 | 17 | $14.2M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding STRATA Skin Sciences, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| 22NW, LP | 0 | $0 | 0.00% | −536,995−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −403,917−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −63,830−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −18,896−100.0% | Sold out |
| Apollon Wealth Management, LLC | 0 | $0 | 0.00% | −15,105−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,093−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −10,016−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −4,465−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,292−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,061−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −123−100.0% | Sold out |
| Financial Perspectives, Inc | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |